A SYBR Green 1-based in vitro test of susceptibility of Ghanaian Plasmodium falciparum clinical isolates to a panel of anti-malarial drugs

BACKGROUND: Based on report of declining efficacy of chloroquine, Ghana shifted to the use of artemisinin-based combination therapy (ACT) in 2005 as the first-line anti-malarial drug. Since then, there has not been any major evaluation of the efficacy of anti-malarial drugs in Ghana in vitro. The se...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Quashie, Neils B, Duah, Nancy O, Abuaku, Benjamin, Quaye, Lydia, Ayanful-Torgby, Ruth, Akwoviah, George A, Kweku, Margaret, Johnson, Jacob D, Lucchi, Naomi W, Udhayakumar, Venkatachalam, Duplessis, Christopher, Kronmann, Karl C, Koram, Kwadwo A
Format: Artigo
Langue:Inglês
Publié: BioMed Central 2013
Sujets:
Research
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3878558/
https://ncbi.nlm.nih.gov/pubmed/24341604
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1475-2875-12-450
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires